Commentary: The Texas Implementation of Medication Algorithms Update for Treatment of Bipolar I Disorder
J Clin Psychiatry 2005;66(7):818-820
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
The Texas Implementation of Medication Algorithms
(TIMA) for the treatment of bipolar I disorder have been updated on the basis of the rapidly evolving
database of new, primarily pharmacologic treatments
for this potentially devastating illness. The revision of the
previous algorithms incorporates data from research studies,
published and unpublished, that have appeared since
the previous algorithms were developed in 2000.1
and panel members have constructed a thoughtful,
thorough scaffold upon which to hang treatment recommendations.